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Background
Asymptomatic Plasmodium spp. infections and anemia are highly prevalent conditions in tropi-
cal regions. We studied whether asymptomatic parasitemia induces hepcidin- and/or cytokine-
mediated iron maldistribution and anemia. 
Design and Methods
A group of 1197 Indonesian schoolchildren, aged 5-15 years, were screened by microscopy for
the presence of parasitemia. Concentrations of hemoglobin, serum hepcidin and parameters of
iron status and inflammation were determined at baseline and 4 weeks after antimalarial treat-
ment.  
Results
Asymptomatic P. falciparum and P. vivax parasitemia were detected in 73 (6.1%) and 18 (1.5%)
children, respectively, of whom 84% and 83% had a C-reactive protein concentration below 5
mg/L. Children with P. falciparum or P. vivax parasitemia had significantly lower hemoglobin
concentrations than 17 aparasitemic controls (12.6 and 12.2 g/dL versus 14.4 g/dL; P<0.01),
together with significantly higher serum hepcidin concentrations (5.2 and 5.6 nM versus 3.1
nM; P<0.05). The latter was associated with signs of iron maldistribution with higher ferritin
concentrations and lower values of serum iron concentration, transferrin saturation and ery-
throcyte mean cell volume. Concentrations of growth differentiation factor 15 were similar
across groups. Antimalarial treatment partly reversed these abnormalities and led to a signifi-
cant increase in hemoglobin concentration.
Conclusions
Asymptomatic malarial parasitemia is associated with increased hepcidin concentrations and
anemia, in the absence of a manifest acute phase response. Prolonged iron maldistribution may
be an underestimated cause of anemia. Screening for parasitemia should be performed before
starting iron supplementation, as iron therapy may be less effective and even hazardous in
these circumstances. 
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Introduction
Infectious diseases induce alterations in the distribution
of iron in the human body. Recent findings have shown
that many of these alterations are attributable to the actions
of the hormone hepcidin.1 Hepcidin inhibits the absorption
of iron through enterocytes and impairs iron release by
macrophages through degradation of ferroportin, the only
iron exporter. Pro-inflammatory cytokines stimulate hep-
cidin expression, which leads to hypoferremia and
increased iron storage in the reticuloendothelial system,
both typical features of the anemia of chronic disease.2
Recent advances in the understanding of iron homeosta-
sis and the development of reliable hepcidin assays offer
new opportunities to improve iron supplementation prac-
tices in regions in which malaria is endemic. Iron deficien-
cy is a common condition in malaria-endemic regions and
its complications are not restricted to anemia, but include
impaired growth, cognitive development and physical
capacity.3 Iron supplementation and iron fortification of
foods have, therefore, been considered important public
health interventions,4 but there is currently growing con-
cern about the safety of iron supplementation in people
exposed to malaria, as iron may increase malaria-associat-
ed morbidity and mortality.5,6
So far, studies on iron homeostasis and malaria have
largely been restricted to symptomatic P. falciparum malar-
ia. However, asymptomatic P. falciparum parasitemia, i.e.
the presence of parasitemia in the absence of fever or
malaria-related symptoms, is also an extremely common
and chronic condition among (semi-)immune persons in
malaria areas, with prevalence rates exceeding 50% in
some areas.7,8 Moreover, up to half of all malaria cases out-
side Africa are caused by P. vivax, which is characterized by
a more indolent and chronic course than P. falciparum,
although it may also ultimately result in severe anemia.9,10
Previously, our group studied hepcidin expression in ane-
mic Tanzanian children with febrile P. falciparum malaria
with high parasite densities and in malaria-naïve Dutch
volunteers who were experimentally infected with P. falci-
parum.11,12 Hepcidin concentrations were increased in both
groups and associated with profound disturbances in iron
homeostasis, suggesting that iron supplements should be
withheld during symptomatic P. falciparum malaria. To our
knowledge, no data are yet available on the effects of
asymptomatic P. falciparum or P. vivax parasitemia on hep-
cidin expression. Due to the chronic and relapsing nature of
both conditions, disturbances in the uptake, recycling and
utilization of iron could play an important and so far under-
recognized role in the pathogenesis of anemia in tropical
areas and reduce the hemoglobin response to iron supple-
ments and iron fortified foods.
The aim of the present study was, therefore, to deter-
mine whether asymptomatic parasitemia induces distur-
bances in iron homeostasis. Concentrations of serum hep-
cidin and a range of hematologic, inflammatory and serum
iron parameters were studied in schoolchildren with
asymptomatic P. falciparum or P. vivax parasitemia on the
Indonesian island Sumba, before and after antimalarial
treatment. Serum concentrations of soluble transferrin
receptor (sTfR) were used as a parameter of erythropoietic
activity and functional iron status. The levels of a recently
discovered negative regulator of hepcidin expression,
growth differentiation factor 15 (GDF15), a molecule
expressed by erythroid precursor cells, were also meas-
ured.13 Finally, we determined the influence of the inherit-
ed red cell disorder Southeast Asian ovalocytosis on iron
homeostasis in our study population. Southeast Asian oval-
ocytosis is highly prevalent on Sumba (estimated preva-
lence 10%)14 and may affect iron homeostasis, as reported
for other red cell disorders.15
Design and Methods
Study site
This study was conducted in the Kodi region of West Sumba
District, East Nusa Tenggara Province, Indonesia, an area with
perennial P. falciparum and P. vivax transmission, stable enough to
induce clinical immunity.16
Study design
This study used archived material collected during in vivo drug
sensitivity tests in the Southwest Sumba District, East Nusa
Tenggara Province, Indonesia. Overall, 1197 children aged 5
through 15 years from seven elementary schools were screened
for the presence of parasitemia by microscopic examination of
thick and thin malaria smears. All malaria smears were read the
same day. The study team returned the following morning and
those children with asymptomatic parasitemia were enrolled after
written informed consent from parents or guardians and consent
from the child. Asymptomatic parasitemia was defined as asexual
P. falciparum or P. vivax parasitemia in the absence of fever (temper-
ature ≤37.9°C) and of clinical signs or symptoms suggestive of
malaria or another infectious disease. Seventeen healthy children
with negative malaria smears were enrolled as a control group. A
history was taken and a short physical examination performed
according to a predefined checklist before 3 mL of venous blood
were drawn into a serum and EDTA tube. Smear-positive children
were treated with a 3-day regimen of artesunate-amodiaquine (P.
falciparum) or a combination regimen of 3 and 7 days of chloro-
quine and primaquine (P. vivax), according to guidelines from the
Indonesian Ministry of Health. Finally, seven subjects with clinical
P. falciparum (n=4) or P. vivax (n=3) malaria who presented to the
local hospital were enrolled as a positive control group.  
To evaluate the effect of treatment of asymptomatic para-
sitemia, a follow-up visit was conducted 4 weeks after antimalar-
ial treatment. The same study procedures were performed as dur-
ing enrollment. The study was carried out with ethical approval
from the Eijkman Institute for Molecular Biology Research Ethics
Committees (Jakarta, Indonesia).
Laboratory methods
Thick and thin blood smears were stained with Giemsa and
examined by a certified microscopist using 1000× oil immersion
light microscopy. Parasite density was quantified against 200
white blood cells and converted to parasites per microliter of
blood using the measured leukocyte count. The blood smear was
also used to assess the presence of ovalocytes, which strongly sug-
gests the presence of Southeast Asian ovalocytosis, a disease that
results from a 27-bp deletion in the band 3 gene.17 Presence of oval-
ocytes in blood smears from Sumbanese was highly predictive for
the presence of the band 3 gene mutation (Dr. Syafruddin, unpub-
lished data). A full blood count was determined by a standard
hematology analyzer (Arcus, Diatron, Vienna, Austria). 
Serum hepcidin was measured using a combination of weak
cation exchange chromatography and time-of-flight mass spec-
trometry (TOF MS). An internal standard (synthetic hepcidin-24;
Peptide International Inc.) was used for quantification.18,19 Peptide
spectra were generated on a Microflex LT matrix-enhanced laser
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desorption/ionization TOF MS platform (Bruker Daltonics).
Serum hepcidin-25 concentrations were expressed in nanomoles.
The lower limit of detection of this method was 0.5 nM; average
coefficients of variation were 2.7% (intra-run) and 6.5% (inter-
run). The median reference level of serum hepcidin-25 concentra-
tions in healthy Dutch adults is 4.2 nM, while the range is 0.5-13.9
nM.20
Serum concentrations of total iron, total iron-binding capacity
(TIBC), ferritin, sTfR and C-reactive protein were determined as
described previously.11,12 GDF15 concentrations were measured
with DuoSet (R&D Systems, Minneapolis, MN, USA) enzyme-
linked immunosorbent assay for human GDF15 according to the
manufacturer’s protocol. Serum concentrations of interleukin-1
receptor antagonist (IL-1ra), interleukin (IL)-6, IL-10 and tumor
necrosis factor-α (TNF-α) were analyzed in one batch using a mul-
tiplex assay (Luminex, Austin, TX, USA) with lower limits of
detection of 7 pg/mL (IL-1ra, IL-6 and IL-10) and 20 pg/mL (TNF-
α). 
Statistical analysis
Differences in characteristics and laboratory parameters
between subjects in the malaria and control groups and among
subjects before and after antimalarial treatment were analyzed by
Student’s t test and paired Student’s t test, respectively. A two-
sided P value of less than 0.05 was considered to be statistically
significant. All analyses were performed with the use of SPSS soft-
ware.
Results
Characteristics 
Of a total of 1197 screened schoolchildren, 73 (6.1%)
had asymptomatic P. falciparum and 18 (1.5%) asympto-
matic P. vivax parasitemia. Seventeen asymptomatic chil-
dren with a negative malaria smear were enrolled as a con-
trol group (see Table 1 for the baseline characteristics).
Only 16% and 17% of children with asymptomatic P. fal-
ciparum and P. vivax parasitemia, respectively, had an ele-
vated (>5 mg/L) C-reactive protein concentration; the
mean C-reactive protein concentration in those children
was 13.7 mg/L (range, 6–39 mg/L). Serum concentrations
of IL-1ra, IL-6, IL-10 and TNF-α were low with values
above the lower detection limit in only 65%, 15%, 38%
and 4% of baseline samples, respectively. Hemoglobin
concentrations were significantly lower in children with
either P. falciparum or P. vivax parasitemia than in controls
(Figure 1). Antimalarial treatment resulted in a modest,
though significant increase in hemoglobin concentration
in both groups with mean concentration increasing from
the baseline 12.6 g/dL to 13.4 g/dL (P<0.01) after treat-
ment in the group with asymptomatic P. falciparum and
from 12.2 g/dL to 13.7 g/dL (P<0.01) in the group with
asymptomatic P. vivax. 
Serum hepcidin and parameters of iron status 
and inflammation
Baseline and week 4 serum concentrations of hepcidin
and IL-1ra and values of the iron status parameters are pre-
sented in Figure 2 and Table 2. Children with asympto-
matic P. falciparum or P. vivax parasitemia had significantly
higher baseline hepcidin concentrations than those of the
control children, together with higher serum ferritin con-
centrations and lower values of serum iron, transferrin sat-
uration, TIBC, mean corpuscular volume and mean cell
hemoglobin. Antimalarial treatment resulted in small but
significant decreases in serum concentrations of hepcidin
and ferritin in both groups with asymptomatic parasitemia.
Hepcidin concentrations decreased by a median of 22%
and 40% in the P. falciparum and P. vivax group, whereas fer-
ritin concentrations decreased by a median of 14% and
30%, respectively. This decrease was associated with small
increases in TIBC (P. falciparum group), mean corpuscular
volume (P. vivax group) and mean cell hemoglobin (both
groups), while the transferrin saturation and serum iron
remained unchanged. There was no change in IL-1ra con-
centrations at week 4. However, C-reactive protein concen-
trations normalized to values below 5 mg/L in 12 of 15 chil-
dren with elevated C-reactive protein concentrations
before antimalarial treatment, while IL-10 concentrations
became undetectable in 10 of 35 children with detectable
IL-10 concentrations at baseline. The effect of antimalarial
treatment on IL-6 and TNF-α concentrations could not be
determined as serum concentrations of the baseline sam-
ples were below the lower detection limit in the vast
majority of children.
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Table 1. Baseline characteristics of the study participants.
Characteristic Asymptomatic Asymptomatic Controls
P. falciparum P. vivax
Number 73 18 17
Age, mean (years; range) 10.9 (6-15) 11.0 (8-15) 10.9 (8-15)
Males, n (%) 39 (53) 11 (61) 10 (59)
Temperature, mean (°C; range) 37.2 (36.7-37.9)* 37.2 (36.7-37.9)** 36.9 (36.6-37.4)
Parasite density, geometric mean (μL-1; range) 189 (34-11.956) 175 (51-2.458) NA
C-reactive protein ≤ 5mg/L, n (%) 61 (84) 15 (83) 9 (100)1
IL-1ra, median (pg/mL; IQR)2 29 (14-61) 14 (9-45) ND
Ovalocytes in blood smear, n. (%) 15 (21%) 1 (6%) ND
Hemoglobin, mean (g/L; 95% CI) 12.6 (12.2-12.9)* 12.2 (11.6-12.9)* 14.4 (13.7-15.1)
WBC, mean (¥109/L; 95% CI) 9.8 (9.2-10.5) 9.4 (7.8-11.0) 9.3 (8.0-10.6)
Platelet count, mean (¥109/L; 95% CI) 289 (266-313)** 235 (184-285)* 360 (310-411)
NA: not applicable; ND,: not determined; IL-1ra: interleukin-1 receptor antagonist; IQR: interquartile range; CI: confidence interval; WBC: white blood cell count. 1C-reactive protein
concentrations available for 9 of 17 controls; 2IL-1ra concentrations above lower detection limit in 66% and 56% of subjects in the P.  falciparum and P.  vivax group, respectively.
* P<0.01, ** P<0.05 compared with controls, calculated using Student’s t test. 
Soluble transferrin receptor and growth 
differentiation factor 15 concentrations
Erythropoietic activity was evaluated by assessment of
serum concentrations of sTfR and GDF15. Both asympto-
matic P. falciparum and P. vivax malaria were associated with
markedly elevated sTfR concentrations, which remained
elevated at week 4 (Figure 3A). In contrast, no differences
in GDF15 concentrations were observed between the
groups (Figure 3B). Erythropoietic activity is a negative reg-
ulator of hepcidin expression and serum concentrations of
sTfR in the children with asymptomatic parasitemia were
indeed inversely correlated with serum hepcidin concentra-
tions (Pearson’s R=-0.33; P=0.002). 
Since no data on GDF15 have previously been reported
in malaria patients, we also determined concentrations of
this protein in seven patients who presented with febrile,
symptomatic P. falciparum (n=4) or P. vivax (n=3) malaria to
the regional hospital. Symptomatic malaria was associated
with lower sTfR concentrations (mean 1.3 mg/L; range,
1.0-2.2 mg/L) and higher GDF15 concentrations (mean
2467 pg/mL; range, 940-4500 pg/mL) when compared with
asymptomatic parasitemia. Although GDF15 has been
reported to down-regulate hepcidin expression, inflamma-
tion was dominant as serum hepcidin concentrations were
markedly elevated (mean 24.3 nM; range 6.8–37.9 nM) in
the presence of high serum concentrations of CRP (mean
83 mg/L; range 14–211 mg/L) and ferritin (mean 713 μg/L;
range, 97-1387 μg/L) and low serum iron concentrations
(mean 3.1 μmol/L; range, 2.0 - 6.0 μmol/L).
Ovalocytosis
Ovalocytes were seen in the blood smear in 15 of 73
(21%) children with asymptomatic P. falciparum para-
sitemia (Table 1), a finding suggestive of Southeast Asian
ovalocytosis. There were no significant differences in
demographic or clinical characteristics between children
with and without ovalocytes (data not shown). No signifi-
cant differences in iron parameters were observed between
the two groups at baseline, except for higher value of mean
Hepcidin and iron parameters in asymptomatic malaria
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Figure 1. Hemoglobin concentrations in children with asymptomatic
P. falciparum parasitemia (n=73), asymptomatic P. vivax parasitemia
(n=18) and controls (n=17). Data depicted are before and 4 weeks
after the start of antimalarial treatment; the line represents the
mean. P values were determined using the Student’s t test and
paired t test. 
Figure 2. Serum concentrations of hepcidin (A), ferritin (B) and
transferrin saturation (C) in children with asymptomatic P. falci-
parum parasitemia (n=73), asymptomatic P. vivax parasitemia
(n=18) and controls (n=17). Data depicted are before and 4 weeks
after the start of antimalarial treatment; the line represents the
mean. P values were determined using the Student’s t test and
paired t test.  
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corpuscular volume and mean cell hemoglobin (Table 3).
By week 4, however, children with ovalocytosis had a
slightly higher sTfR concentration, together with lower
serum concentrations of hepcidin, serum iron, ferritin and
transferrin saturation (Table 3). In addition, while anti-
malarial treatment induced a significant rise in hemoglobin
concentration in the group without ovalocytosis, there was
no change in hemoglobin or serum ferritin concentrations
in the group with ovalocytosis.
Discussion
The present study shows that serum hepcidin concentra-
tions are increased in children with asymptomatic P. falci-
parum and P. vivax parasitemia in the absence of a marked
acute phase response. These higher hepcidin concentra-
tions were accompanied by findings suggestive of iron
maldistribution, i.e. higher serum ferritin concentrations
and lower values of serum transferrin saturation, serum
iron concentration and mean corpuscular volume.
Antimalarial treatment partly reversed these abnormalities
and resulted in a significant increase in hemoglobin concen-
tration and significant decreases in serum concentrations of
hepcidin and ferritin. 
Are these mildly elevated hepcidin concentrations func-
tionally important, i.e. do they reduce the availability of
iron for erythropoiesis? We recently showed in an experi-
mental human malaria model that even a mild increase in
serum hepcidin, to concentrations in the range of those
observed in the current study, induces hypoferremia and a
steep fall in the hemoglobin content of reticulocytes, which
is suggestive of impaired iron incorporation in hemoglo-
bin.12 Moreover, the lower values of hemoglobin, mean cor-
puscular volume, serum iron concentration and transferrin
saturation in children with asymptomatic parasitemia also
support the presence of functional iron deficiency. Since
asymptomatic P. falciparum and P. vivax parasitemia are
chronic and relapsing conditions, a possible delocalization
of iron with iron retention in monocytes/ macrophages
may theoretically increase the risk of anemia and of infec-
tions with intracellular bacteria (e.g. Salmonella and
Mycobacteria spp.), which are extremely common in regions
in which malaria is endemic. We, therefore, suggest screen-
ing individual children in malaria areas for the presence of
malaria when iron therapy is considered and including
malaria screening and treatment as an integral part of uni-
versal iron supplementation programs. In addition, as
Q. de Mast et al.
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Table 2. Serum hepcidin and iron parameters (mean with 95% confidence
interval) at baseline and 4 weeks after antimalarial treatment.
Characteristic Asymptomatic  Asymptomatic Controls
P. falciparum P. vivax
Serum hepcidin (nM)
week 0 5.2 (4.4-6.1)** 5.6 (3.8-7.4)** 3.1 (1.7-4.6)
week 4 4.1 (3.5-4.8)## 3.0 (1.7-4.3)#
Serum ferritin (μg/L)    
week 0 75 (60-96)* 101 (72-130)* 47 (35-59)
week 4 59 (49-70)# 65 (48-82)#
Serum transferrin saturation (%)
week 0 14.3 (12.8-15.9)** 14.3 (11.2-17.4)** 19.2 (13.5-24.9)
week 4 14.6 (13.2-16.1) 13.7 (11.0-16.4)
Serum iron (μmol/L)
week 0 8.6 (7.8-9.4)* 8.9 (7.1-10.7)** 13.3 (8.4-18.3)
week 4 9.3 (8.4-10.2) 8.9 (7.2-10.7)
Serum TIBC (μmol/L)
week 0 62 (60-64) 63 (59-68) 69 (60-77)
week 4 65 (63-67)# 65 (48-82)
Mean corpuscular volume (fL)
week 0 81.4 (79.8-83.0)** 78.6 (74.8-82.3) 83.7 (78.1-89.3)
week 4 81.3 (79.7-82.9) 79.5 (75.3-83.8)#
Mean cell hemoglobin (pg)
week 0 26.7 (26,0-27,3)* 25,6 (23,9-27,4)* 29.8 (27.3-32.3)
week 4 26.9 (26.2-27.3)## 26.3 (24.3-28.2)#
IL-1ra (pg/mL)1
week 0 29 (14-61) 14 (9-45) ND
week 4 25 (14-53) 14 (7-29)
TIBC, total iron binding capacity; IL-1ra, interleukin-1 receptor antagonist; ND, not determined.
1Data represent median and interquartile range. Values above the lower limit of detection in 66%
and 56% of week 0 samples in the P. falciparum and P. vivax groups, respectively. *P<0.01,
**P<0.05 versus controls by Student’s t test. #P<0.01, ##P<0.05 versus corresponding week 0 val-
ues by paired t test.
Figure 3. Serum concentrations of soluble transferrin receptor (A)
and growth differentiation factor 15 (B) in children with asympto-
matic P. falciparum parasitemia (n=73), asymptomatic P. vivax par-
asitemia (n=18) and controls (n=17). Data depicted are before and
4 weeks after the start of antimalarial treatment; the line repre-
sents the mean. P values determined using the Student’s t test and
paired t test. 
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recently proposed by Theurl et al. and by our group, hep-
cidin is a promising new parameter for the selection of indi-
viduals who will benefit from iron therapy.11,12,21
The exact cause of the up-regulated hepcidin production
in asymptomatic malaria remains speculative. Previous
studies found only little inflammation in patients with
asymptomatic parasitemia, which is in line with the low
circulating concentrations of C-reactive protein and inflam-
matory cytokines in our present study.22 Therefore, even
though an effect of mild inflammation cannot be fully
excluded, other mechanisms should be considered. Recent
work by Armitage et al. showed that P. falciparum-para-
sitized erythrocytes directly up-regulate hepcidin produc-
tion by peripheral blood mononuclear cells via pattern
recognition receptors.23 Our earlier observations, in children
with febrile malaria, that IL-6 concentrations were inde-
pendent of urine hepcidin concentrations in multivariate
regression analysis are also consistent with the existence of
such an IL-6-independent pathway in malaria.11
Erythropoietic activity is also increasingly recognized as
a central regulator of hepcidin production.24 Although the
precise pathways are yet to be elucidated, two novel ery-
throid regulators, TWSG1 (twisted gastrulation homolog 1)
and GDF15, were recently shown to down-regulate hep-
cidin expression.13,25 GDF15 is a molecule expressed by ery-
throid precursors and increased GDF15 concentrations
have been found in patients with thalassemia major and
other conditions with ineffective erythropoiesis.13,26,27
Although earlier bone marrow studies in subjects with low
density P. falciparum and with P. vivaxmalaria were sugges-
tive of ineffective erythropoiesis, the normal GDF15 con-
centrations in our present study do not support this.28-30
Instead, as also previously reported by Verhoef et al.,31 the
elevated sTfR concentrations, a parameter thought to cor-
relate well with erythroid mass,32 suggests that erythro-
poiesis is effectively increased in asymptomatic para-
sitemia. Increased erythropoietic activity compensating for
increased red cell destruction may negate some of the hep-
cidin-stimulatory effects of malaria antigen or inflamma-
tion. In contrast, erythropoiesis is usually suppressed in
symptomatic malaria, as reflected by the low sTfR concen-
trations together with elevated GDF15 concentrations in
the seven patients with febrile malaria in our study.33
Southeast Asian ovalocytosis is a common inheritable
red blood cell disorder on the island of Sumba. It results
from a 27-base pair deletion in the band 3 gene, which
leads to rigid and oval-shaped red blood cells. In our study,
the presence of ovalocytes in the blood smear, a finding
highly suggestive of Southeast Asian ovalocytosis,17 was
related to higher sTfR concentrations and normal GDF15
concentrations. A reduced life span of ovalocytes with a
compensatory increase in erythropoiesis may account for
this finding and may also explain why antimalarial treat-
ment resulted in a greater decrease in serum hepcidin con-
centrations. By contrast, no changes in hemoglobin and fer-
ritin concentrations were observed in the ovalocytosis
group, a finding not readily explained though possibly
related to ongoing low-grade hemolysis and erythrophago-
cytosis of the rigid ovalocytes. Finally, thalassemia may
also influence iron homeostasis, but this hemoglobinopa-
thy seemed rare in our study population because less than
7% of children had microcytosis (<70 fL), a finding that is
considered typical of thalassemia. Moreover, none of these
children with microcytosis also had strongly elevated con-
centrations of sTfR and GDF15, which are usually present
in thalassemia intermedia or major.13
In conclusion, asymptomatic P. falciparum and P. vivax
parasitemia were associated with lowered hemoglobin
concentrations and increased serum hepcidin concentra-
tions in the absence of marked inflammation. Antimalarial
treatment resulted in a decrease in serum hepcidin concen-
trations and an increase in hemoglobin concentrations,
although a causal relationship between these findings is
unproven. We speculate that asymptomatic parasitemia
with impaired iron handling may be an underestimated
cause of anemia in tropical countries. We suggest that uni-
versal iron supplementation programs should not be imple-
mented without proper screening for parasitemia and func-
tional iron deficiency. Hepcidin may prove a useful screen-
ing tool for this purpose.
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Table 3. Hematologic and iron parameters (mean with 95% confidence
interval) in children with and without ovalocytosis.
Characteristic Ovalocytosis No ovalocytosis P
(n=15) (n=58) value
Hemoglobin (g/dL)
week 0 12.7 (12.1-13.4) 12.5 (12.1-12.9) 0.58
week 4 12.8 (12.2-13.4) 13.6 (13.3-13.9)* 0.034
Serum hepcidin (nM)
week 0 4.6 (2.6-6.5) 5.4 (4.5-6.3) 0.41
week 4 2.8 (1.5-4.1)** 4.5 (3.7-5.2) 0.042
Serum sTfR (mg/L) 
week 0 2.8 (2.4-3.2) 2.4 (2.2-2.6) 0.09
week 4 2.8 (2.4-3.2) 2.4 (2.2-2.5) 0.046
Serum GDF15 (pg/mL)
week 0 430 (362-499) 441 (413-469) 0.73
week 4 414 (355-472) 436 (409-463) 0.46
Serum ferritin (μg/L)
week 0 79 (50-108) 74 (55-94) 0.82
week 4 80 (38-121) 54 (46-63) 0.047
Serum iron (μmol/L)
week 0 9.4 (7.4-11.4) 8.4 (7.6-9.3) 0.34
week 4 11.4 (9.0-13.9) 8.8 (7.8-9.7) 0.017
Serum transferrin saturation (%)
week 0 17.9 (13.8-22.0) 14.2 (12.4-16.1) 0.79
week 4 14.8 (11.8-17.7) 13.8 (12.3-15.3) 0.021
Mean corpuscular volume (fL)
week 0 84.2 (81.7–86.7) 80.7 (78.9-82.6) 0.054
week 4 83.9 (81.5–86.2) 80.6 (78.7-82.5) 0.031
Mean cell hemoglobin (pg)
week 0 27.6 (26.5-28.8) 26.4 (25.6-27.2) 0.058
week 4 28.0 (26.9-29.1) ** 26.6 (25.8-27.5) 0.059
Data from baseline and week 4 after starting 3 days of antimalarial treatment. sTfR, sol-
uble transferrin saturation. GDF15, growth differentiation factor-15; P values in last col-
umn are for the difference between the ovalocytosis and no ovalocytosis groups, calcu-
lated with Student’s t test. *P<0.01, **P<0.05 versus corresponding week 0 values with-
in groups by paired t test.
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